Look for New GLP-1 Agonists for Type 2 Diabetes
February 2018
You'll see Adlyxine (ad-LIKS-een, lixisenatide) and Ozempic (oh-ZEM-pik, semaglutide) join the crowded field of GLP-1 agonists.
Adlyxine is available now...and Ozempic will be in March. This will bring the tally in Canada to six GLP-1 agonist products for diabetes.
Be familiar with how the different agents compare.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive